Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRIDES PHARMA SCIENCE LIMITED Call Transcript 2023

Oct 30, 2023

62616_rns_2023-10-30_8a47c746-914f-4bf5-af4d-18eb3564b637.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [154 x 50] intentionally omitted <==

October 30, 2023

BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 Scrip code: 532531

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E) Mumbai - 400 051 Scrip code: STAR

Dear Madam/ Sirs,

Sub: Audio Recording of Earnings call pertaining to the un-audited Financial Results for the quarter and half year ended September 30, 2023.

Pursuant to Regulation 46 & 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the link of audio recording of earnings call pertaining to the un-audited financial results of the Company for the quarter and half-year ended September 30, 2023 held today, Monday, October 30, 2023. The Results were approved by the Board in its meeting held today.

Link URL: https://ccreservations.com/recordings/select_recordings.php
Recording Id: STD0520231030149617

The same can also be accessed on the Company’s website at: - https://www.strides.com/investor annualreport.html

Request you to kindly take the above on record.

Thanks & Regards,

For Strides Pharma Science Limited,

MANJULA Digitally signed by MANJULA RAMAMURT RAMAMURTHY Date: 2023.10.30 HY 17:30:28 +05'30' Manjula R Company Secretary ICSI Membership No. A30515

==> picture [500 x 48] intentionally omitted <==